MARLISSA Drug Patent Profile
When do Marlissa patents expire, and when can generic versions of Marlissa launch?
Marlissa is a drug marketed by Glenmark Pharms Ltd and is included in one NDA.
The generic ingredient in MARLISSA is ethinyl estradiol; levonorgestrel. There is one drug master file entry for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MARLISSA?
- What are the global sales for MARLISSA?
- What is Average Wholesale Price for MARLISSA?
Summary for MARLISSA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 9 |
| Patent Applications: | 692 |
| Drug Sales Revenues: | Drug sales revenues for MARLISSA |
| DailyMed Link: | MARLISSA at DailyMed |
US Patents and Regulatory Information for MARLISSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | MARLISSA | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 091452-001 | Feb 29, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |


